Scripps Translational Science Institute

Scripps researchers estimate that there could have been as many as 30 different introductions of the Zika virus into Florida, Medscape Medical News says.

Researchers found evidence that mutations and age-related methylation signatures tend to persist in induced pluripotent stem cells from the elderly.

Investigators plan to expand the program nationwide, with the hope that it can help guide care for living family members and further understanding of causal diseases.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.

Genome sequences for 600 disease-free individuals over 80 years old suggest protective variants related to cognition may mitigate disease and boost healthspan.

The company said it has enlisted 23 academic and medical institutions to supply patient samples that will support the validation and launch of its tests.

The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method. 

The price of WGS is at that "magic number" everyone has been waiting for, but is it enough to take genomics mainstream?

The goal of the Molecular Autopsy study is to identify genes that are associated with sudden death and previously unrecognized genetic mechanisms for the cases. 

Next-generation sequencing is steadily gaining acceptance in the healthcare community, but even ardent supporters of the technology cautioned at a recent conference that the approach should not be considered a silver bullet that can solve all previously intractable medical cases,

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.